| A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection (NCT00000652) | National Cancer Institute (NCI) | |
| A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma (NCT00000694) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time (NCT00001002) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility (NCT00002006) | Sandoz | |
| Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders (NCT00002153) | DEKK-TEC, Inc. | |
| Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke (NCT00005883) | NYU Langone Health | |
| A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine (NCT00000628) | Merck Sharp & Dohme LLC | |
| A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP (NCT00000998) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals (NCT00002087) | Pharmacia and Upjohn | |
| A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV (NCT00001049) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects (NCT00932763) | Torrent Pharmaceuticals Limited | |
| Evaluation of Lovastatin in Severe Persistent Asthma (NCT00689806) | University of Chicago | |
| The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months (NCT00006279) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers (NCT00989872) | Enanta Pharmaceuticals, Inc | |
| Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition (NCT01089166) | Torrent Pharmaceuticals Limited | |
| A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160 (NCT00000745) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes (NCT00013910) | National Center for Research Resources (NCRR) | |
| A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma (NCT01353482) | University College, London | |
| A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults (NCT00001096) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies (NCT00000888) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis (NCT00345137) | Regional Hospital Holstebro | |
| A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection (NCT00000669) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia (NCT02215629) | Verastem, Inc. | |
| NI-0801 in Allergic Contact Dermatitis (NCT01244607) | Light Chain Bioscience - Novimmune SA | |
| Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals (NCT00000664) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS (NCT00000987) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Clinical Investigation on the Acoustic Stimulation in the Treatment of Chronic Tinnitus (NCT00927121) | ANM Adaptive Neuromodulation GmbH | |
| A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children. (NCT00000833) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition (NCT00940238) | Torrent Pharmaceuticals Limited | |
| A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients (NCT00002350) | Apollon | |
| Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases (NCT02145910) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | |
| GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease (NCT00228839) | Emory University | |
| The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation (NCT01981668) | Nova Scotia Cancer Centre | |
| Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors (NCT00004979) | Jonsson Comprehensive Cancer Center | |
| Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer (NCT00268255) | Barbara Ann Karmanos Cancer Institute | |
| GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers (NCT01437280) | Baylor College of Medicine | |
| Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults (NCT00119873) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Ixabepilone and Pemetrexed/Solid Tumors (NCT01170871) | University of Southern California | |
| Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC (NCT00000711) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis (NCT00344916) | Regional Hospital Holstebro | |
| Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults (NCT00115960) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV (NCT00001105) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions (NCT01800240) | Torrent Pharmaceuticals Limited | |
| Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions. (NCT01218711) | Torrent Pharmaceuticals Limited | |
| Bioequivalence Study of Torrent Pharmaceutical Limited's Isosorbide Mononitrate 120 mg ER Tablets Under Fed Conditions (NCT01418547) | Torrent Pharmaceuticals Limited | |
| Comparative Pharmacokinetic Trial of RGB-03 and MabThera (NCT02371096) | Gedeon Richter Plc. | |
| A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients (NCT00000699) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients (NCT00017823) | National Institute of Nursing Research (NINR) | |
| SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00005996) | Jonsson Comprehensive Cancer Center | |
| The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine (NCT00001112) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions (NCT01418625) | Torrent Pharmaceuticals Limited | |
| A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) (NCT00000968) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome (NCT00000737) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Peldesine (BCX-34) in HIV-Infected Patients (NCT00002237) | BioCryst Pharmaceuticals | |
| Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions (NCT01931501) | Torrent Pharmaceuticals Limited | |
| Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn) (NCT00000630) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Ertapenem Distribution in the Muscle of Six Healthy Volunteers and Six Critically Ill Patients by Microdialysis (NCT01061047) | Poitiers University Hospital | |
| Evaluation of the Proximal Femoral Nail Antirotation With Cement Augmentation in Osteoporotic Femoral Neck Fractures (NCT01235169) | Hadassah Medical Organization | |
| A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study) (NCT00001020) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| GO-203-2C + Bortezomib For Relapsed Or Refractory MM (NCT02658396) | Dana-Farber Cancer Institute | |
| Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS (NCT00000646) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers (NCT00959777) | Dong-A ST Co., Ltd. | |
| A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo (NCT02223416) | Gedeon Richter Plc. | |
| A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs (NCT00002206) | Gilead Sciences | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex (NCT00002004) | Genentech, Inc. | |
| Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection (NCT00002078) | Purdue Frederick | |
| Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma (NCT00000695) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction Therapy (NCT00297921) | Millennium Pharmaceuticals, Inc. | |
| A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine) (NCT00000775) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3 (NCT00000755) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fasted Conditions (NCT01418586) | Torrent Pharmaceuticals Limited | |
| Treatment of Uremic Pruritus by Olive-omega 3 Ointment (NCT01447693) | Assaf-Harofeh Medical Center | |
| A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3 (NCT00002129) | Otsuka America Pharmaceutical | |
| Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction (NCT00037804) | Pfizer | |
| Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fasting Conditions (NCT01419340) | Torrent Pharmaceuticals Limited | |
| The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children (NCT00000865) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions (NCT01634399) | Torrent Pharmaceuticals Limited | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection (NCT00000663) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura (NCT00002250) | Genentech, Inc. | |
| A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women (NCT00915668) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Pharmacokinetic Study of Marine Active in Health Men (NCT00207974) | China Medical University Hospital | |
| BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment (NCT00005611) | H. Lee Moffitt Cancer Center and Research Institute | |
| Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel (NCT01539876) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | |
| A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS (NCT00000966) | Pfizer | |
| CT 327 in the "Atopy Patch Test" Model (NCT01368315) | Creabilis SA | |
| A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction (NCT00215124) | The Cleveland Clinic | |
| A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex (NCT00000988) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients (NCT00306566) | Cytos Biotechnology AG | |
| Study of Enfuvirtide in HIV-Positive Subjects (NCT00086710) | Trimeris | |
| A Study of BufferGel in Women (NCT00000927) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection (NCT00002119) | Oxo Chemie GmbH | |
| MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer (NCT01240928) | Vanderbilt-Ingram Cancer Center | |
| "Loss of Resistance" Versus CompuFlo® for Epidural Placement (NCT00178750) | The University of Texas Health Science Center, Houston | |
| A Study of MDL 28,574A in HIV-Infected Patients (NCT00002329) | Hoechst Marion Roussel | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer (NCT00120939) | Pharmacyclics LLC. | |
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B) (NCT00000767) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects (NCT00000798) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets (NCT00914004) | Sandoz | |
| Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer (NCT00137358) | University of Alabama at Birmingham | |
| First in Humans Study of JDTic (NCT01431586) | RTI International | |